ACM
BLTE

ADAR1 Capital Management’s Belite Bio BLTE Stock Holding History

ADAR1 Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.29M Sell
26,880
-12,959
-33% -$2.18M 0.25% 84
2025
Q4 		$6.37M Buy
+39,839
New +$4.72M 0.47% 45

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management's BLTE Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Belite Bio (BLTE) stake by 33% in Q1 2026, selling an estimated $2.18M and leaving 26,880 shares worth $4.29M. The position accounts for 0.25% of the portfolio, ranked #84.

ADAR1 Capital Management first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.37M in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • ADAR1 Capital Management held 26,880 shares of Belite Bio worth $4.29M as of Q1 2026.
  • ADAR1 Capital Management sold 12,959 Belite Bio shares in Q1 2026, an estimated $2.18M.
  • Belite Bio made up 0.25% of ADAR1 Capital Management's portfolio in Q1 2026, its #84 holding.
  • ADAR1 Capital Management first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
  • ADAR1 Capital Management's Belite Bio position peaked at $6.37M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.